Olympiad Research’s Edwards Lifesciences EW Stock Holding History

Olympiad Research’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-4,462	Closed	-$421K	–	340
2023 Q2	$421K	Sell	4,462 -1,475	-25%	-$128K	0.41%	63
2023 Q1	$491K	Buy	+5,937	New	+$467K	0.57%	35
2022 Q3	$237K	Buy	+2,866	New	+$276K	0.13%	183
2020 Q3	–	Sell	-3,466	Closed	-$240K	–	381
2020 Q2	$240K	Buy	3,466 +184	+6%	+$13.1K	0.17%	174
2020 Q1	$206K	Sell	3,282 -846	-20%	-$61K	0.21%	194
2019 Q4	$321K	Buy	+4,128	New	+$322K	0.25%	76

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Olympiad Research's EW Position: Q3 2023 in Review

Olympiad Research sold out of Edwards Lifesciences (EW) in Q3 2023, closing a stake of 4,462 shares — an estimated $421K sold.

Olympiad Research first reported a position in EW in Q4 2019 and held it in 6 quarters. The position peaked at $491K in Q1 2023. 1,220 funds tracked by Wall St. Rank hold EW as of Q3 2023.

Olympiad Research reported no remaining Edwards Lifesciences position as of Q3 2023 after selling out during the quarter.
Olympiad Research sold 4,462 Edwards Lifesciences shares in Q3 2023, an estimated $421K.
Olympiad Research first reported a position in Edwards Lifesciences in Q4 2019 and held it in 6 quarters.
Olympiad Research's Edwards Lifesciences position peaked at $491K in Q1 2023.
1,220 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2023.

Based on Olympiad Research's 13F filing for Q3 2023, filed 2 Nov 2023.